BOSTON (TheStreet) -- U.S. stocks gained Monday as investors weighed the implications of the health care bill passed by the House of Representatives. These stocks hit highs.

3. Qwest Communications ( Q) rose 3% to $5.17, recording a high of $5.22. Shares of the telecom company have gained 17% in the past month.

Quarter: Fourth-quarter profit tumbled 39% to $108 million, or 6 cents a share, as revenue fell 9.7% to $3 billion. The operating margin narrowed from 17% to 15%. Qwest Communications holds $2.4 billion of cash and $14 billion of debt.

Stock: Qwest Communications has appreciated 52% in the past year, matching the S&P 500 Index. The stock trades at a price-to-projected-earnings ratio of 15, a 16% premium to its peer-group average. It's cheap based on sales and cash flow.

Consensus: Of analysts covering Qwest, 11, or 44%, advise purchasing its shares, 12 recommend holding and two suggest selling them. Citigroup ( C), Barclays ( BCS) and Bank of America ( BAC) expect the stock to advance 15% to $6.

2. Clorox ( CLX) ascended 0.8% to $64.92, hitting a high of $64.98. Shares of the consumer products company have returned 6.4% in the past four weeks.

Quarter: Fiscal second-quarter profit increased 28% to $110 million, or 77 cents, as revenue grew 5.2% to $1.3 billion. Clorox's operating margin extended from 15% to 17%. Its balance sheet contains $154 million of cash and $3 billion of debt.

Stock: Clorox has returned 31% during the past year, less than major benchmarks. The stock sells for a price-to-projected-earnings ratio of 14, a 10% discount to the industry average. It's also cheap based on trailing earnings and sales.

Consensus: Of researchers following Clorox, eight rate its stock "buy", 10 rate it "hold" and one ranks it "sell." UBS ( UBS) expects the shares to rise 17% to $76. Jefferies is also bullish on the stock. TheStreet's model expects it to hit $77.77.

1. The Gap ( GPS) climbed 0.8% to $23.40, achieving a high of $23.51. Shares of the clothing retailer have jumped 18% in the past month.

Quarter: Fourth-quarter profit increased 45% to $352 million, or 51 cents, as revenue increased 3.8% to $4.2 billion. The Gap's operating margin extended from 9.8% to 14%. Its balance sheet stores $2.6 billion of cash and no debt.

Stock: The Gap has nearly doubled during the past year, outperforming U.S. indices. The stock trades at a price-to-projected-earnings ratio of 13, a 27% discount to its peer-group average. It's also cheap based on trailing earnings and cash flow.

Consensus: Of analysts covering The Gap, 14, or 45%, advocate purchasing its shares, 14 counsel holding and three say to sell. Caris, Credit Suisse ( CS) and Societe Generale expect the stock to hit $28, a potential 19% gain.

See Stockpickr's 52-Week High Portfolio

More from Investing

General Electric's Stock Price Is at a Crossroads

General Electric's Stock Price Is at a Crossroads

Adobe-Magento Deal Highlights Escalating Cloud Wars

Adobe-Magento Deal Highlights Escalating Cloud Wars

Did Trump Just Torpedo the Stock Market Again?

Did Trump Just Torpedo the Stock Market Again?

10 Questions for PayPal Ahead of Its Big Investor Day

10 Questions for PayPal Ahead of Its Big Investor Day

Lowe's Q1 Miss Emerges as Home Depot Veteran Arrives

Lowe's Q1 Miss Emerges as Home Depot Veteran Arrives